Quanshun Li Selected Research

Quanshun Li Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 01/2011
8	Lung Neoplasms (Lung Cancer) 03/2022 - 11/2012
4	Adenocarcinoma of Lung 10/2021 - 10/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 03/2013
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Hemolysis 01/2019 - 11/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2015
1	Melanoma (Melanoma, Malignant) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Colitis 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Hand-Foot Syndrome 01/2021
1	Infections 08/2019
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Breast Neoplasms (Breast Cancer) 05/2015
1	Neoplasm Metastasis (Metastasis) 05/2015
1	Carcinoma (Carcinomatosis) 03/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

8	Poly(amidoamine)IBA 01/2022 - 10/2016
7	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 03/2013
6	PolyethyleneimineIBA 03/2022 - 10/2014
5	benzeneboronic acidIBA 01/2021 - 10/2016
4	Pharmaceutical PreparationsIBA 10/2021 - 11/2016
4	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2016
3	N-isopropylacrylamideIBA 03/2022 - 05/2015
3	AminesIBA 01/2019 - 10/2016
3	OligonucleotidesIBA 05/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 05/2015
2	2-amino-6-chloropurineIBA 01/2022 - 10/2017
2	Adenosine Triphosphate (ATP)IBA 10/2021 - 01/2017
2	MicellesIBA 01/2021 - 11/2012
2	Dendrimers (Dendrons)IBA 03/2019 - 01/2017
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 01/2019 - 10/2017
2	EstersIBA 01/2019 - 05/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2017
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2017 - 12/2015
2	Cisplatin (Platino)FDA LinkGeneric 05/2015 - 11/2012
2	methoxypoly(ethylene glycol)-block-poly(glutamic acid)IBA 03/2013 - 11/2012
2	Silybin (Lagosa)IBA 03/2013 - 01/2011
1	Colloids (Colloid)IBA 03/2022
1	Dextran SulfateIBA 01/2022
1	Metal-Organic FrameworksIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Nanoparticle Drug Delivery SystemIBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	PolymersIBA 10/2021
1	SolutionsIBA 10/2021
1	ArtesunateIBA 10/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2021
1	Thioctic Acid (Lipoic Acid)IBA 08/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	C.I. direct red 80IBA 01/2021
1	1-dodecylpyridoxal (PLD)IBA 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	AGRO 100IBA 01/2021
1	NucleolinIBA 01/2021
1	CollagenIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2019
1	Biocompatible Materials (Biomaterials)IBA 08/2019
1	Dz13 DNAzymeIBA 01/2019
1	imidazoleIBA 01/2019
1	CholesterolIBA 01/2019
1	genipinIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	LipidsIBA 10/2017
1	Hyaluronic Acid (Hyaluronan)IBA 10/2017
1	Disulfiram (Antabuse)FDA Link 01/2017
1	thiazolyl blueIBA 01/2017
1	Caspase 3 (Caspase-3)IBA 11/2015
1	acetylleucineIBA 11/2015
1	CurcuminIBA 09/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2015
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 05/2015
1	Dextrans (Dextran)FDA Link 05/2015
1	Peptides (Polypeptides)IBA 05/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2015
1	Catalytic DNA (Deoxyribozyme)IBA 01/2015
1	Aurora Kinase AIBA 01/2015
1	Glutamic Acid (Glutamate)FDA Link 03/2013
1	FlavonoidsIBA 03/2013

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2011
6	Drug Therapy (Chemotherapy) 01/2021 - 10/2014
3	Intravenous Injections 01/2022 - 01/2017
2	Lasers (Laser) 01/2021 - 01/2019
1	Immunotherapy 01/2022
1	Oral Administration 01/2022
1	Microspheres (Microsphere) 10/2021
1	Induced Hyperthermia (Thermotherapy) 09/2015